Shanghai Pharmaceutical Co., Ltd. is a medical drug manufacturer, whose main business covers drug R&D, manufacturing, distribution and retail. It owns many brands such as Xinyi, Schleswig and Longhu. Its main products include Bifidobacterium triple viable capsule, polysaccharide-iron composite capsule, Rupixiao and so on. Can be used for treating digestive tract and metabolism, urogenital system, central nervous system, blood and hematopoietic organs. The company's main income sources are drug retail income, patent licensing income and distribution income.
More peer analysis, the company knows and understands.